TCR-T cells for post-HCT leukemia recurrence; platelets are the predominant source of procoagulant membranes in hemostasis; BR + R maintenance for MCL
September 5, 202418m 10s
Audio is streamed directly from the publisher (prfx.byspotify.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this week's episode we'll discuss HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation. Next, we'll learn about how 4D intravital imaging in mice reveals the key role of platelets as a source of procoagulant membranes in hemostasis. Finally, we'll hear about modifications to a common induction and maintenance treatment for treatment-naïve mantle-cell lymphoma.
Featured Articles
- HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell
transplantation - 4D intravital imaging studies identify platelets as the predominant cellular procoagulant surface in a mouse
hemostasis model - Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with
rituximab ± lenalidomide for MCL
Topics
hematologyoncologymedicalmedical researchlymphomaleukemiaCAR Tred cells